Gilead emerges victorious in HIV drug patent lawsuit against US government.
TL;DR
A federal jury in Delaware has ruled that the US government does not have an ownership claim to lucrative drugs to prevent HIV that are sold by Gilead Sciences. The verdict marked a defeat for the government and activists who have pushed it to more aggressively assert its financial and legal rights to medicines developed with the help of public funding. The legal dispute centered on who devised the idea of using a Gilead medication for people at high risk of contracting HIV, which causes AIDS.
Topics:businesshealth#gilead-sciences#government-lawsuit#health#hiv-prevention#patent-infringement#truvada
- Gilead Wins Key Patent Rights Suit Over HIV Prevention Drug PrEP The New York Times
- Gilead Sciences defeats U.S. government lawsuit alleging HIV drug patent violations CNBC
- Gilead Sciences prevails in US government lawsuit over HIV drug patents Reuters
- U.S. Loses Key Case on Rights to H.I.V.-Prevention Drugs The New York Times
- Gilead, US square off in billion-dollar HIV drug patent trial Reuters
Want the full story? Read the original reporting
Read on The New York Times